Decellularization and cell seeding of whole liver biologic scaffolds composed of extracellular matrix

Journal of Clinical and Experimental Hepatology

Volumn 5, Issue 1, 2015, Pages 69-80

  Faulk, Denver M ^a,b   Wildemann, Justin D ^a   Badylak, Stephen F ^a,b,c  

^a University of Pittsburgh   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Biologic scaffold; Decellularization; Extracellular matrix; Liver tissue engineering; Organ engineering

Indexed keywords

COLLAGEN; ELASTIN; GLYCOSAMINOGLYCAN; TRYPSIN;

CELL DIFFERENTIATION; CELL INTERACTION; CELL SEEDING; CELLS BY BODY ANATOMY; DECELLULARIZATION; DEGRADATION; EXTRACELLULAR MATRIX; HUMAN; INNATE IMMUNITY; LIVER CELL; LIVER GRAFT; LIVER REGENERATION; LIVER TRANSPLANTATION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROCEDURES CONCERNING CELLS; REVIEW; TISSUE ENGINEERING; TISSUE SCAFFOLD;

EID: 84928699173     PISSN: 09736883     EISSN: 22133453     Source Type: Journal    
DOI: 10.1016/j.jceh.2014.03.043     Document Type: Review

References (77)

1. Fuhrman C., Jougla E., Nicolau J., Eilstein D., Delmas M.C. Deaths from chronic obstructive pulmonary disease in France, 1979-2002: a multiple cause analysis. Thorax 2006, 61(11):930-934. PubMed PMID: 16738039; PubMed Central PMCID: PMC2121171. 10.1136/thx.2006.061267.
2. Bonavita A.G., Quaresma K., Cotta-de-Almeida V., et al. Hepatocyte xenotransplantation for treating liver disease. Xenotransplantation 2010, 17(3):181-187. Epub 2010/07/20, PubMed PMID: 20636538. 10.1111/j.1399-3089.2010.00588.x.
3. Fiegel H.C., Kaufmann P.M., Bruns H., et al. Hepatic tissue engineering: from transplantation to customized cell-based liver directed therapies from the laboratory. JCell Mol Med 2008, 12(1):56-66. Epub 2007/11/21, PubMed PMID: 18021311. 10.1111/j.1582-4934.2007.00162.x.
4. Diekmann S., Bader A., Schmitmeier S. Present and future developments in hepatic tissue engineering for liver support systems: state of the art and future developments of hepatic cell culture techniques for the use in liver support systems. Cytotechnology 2006, 50(1-3):163-179. Epub 2008/11/13, PubMed PMID: 19003077; PubMed Central PMCID: PMC3476010. 10.1007/s10616-006-6336-4.
5. Zhou P., Lessa N., Estrada D.C., et al. Decellularized liver matrix as a carrier for the transplantation of human fetal and primary hepatocytes in mice. Liver Transpl 2011, 17(4):418-427. Epub 2011/03/30, PubMed PMID: 21445925; PubMed Central PMCID: PMC3079538. 10.1002/lt.22270.
6. Barakat O., Abbasi S., Rodriguez G., et al. Use of decellularized porcine liver for engineering humanized liver organ. JSurg Res 2012, 173(1):e11-e25. Epub 2011/11/22, PubMed PMID: 22099595. 10.1016/j.jss.2011.09.033.
7. Soto-Gutierrez A., Zhang L., Medberry C., et al. Awhole-organ regenerative medicine approach for liver replacement. Tissue Eng Part C Methods 2011, 17(6):677-686. Epub 2011/03/08, PubMed PMID: 21375407; PubMed Central PMCID: PMC3103054. 10.1089/ten.tec.2010.0698.
8. Sampey B.P., Stewart B.J., Petersen D.R. Ethanol-induced modulation of hepatocellular extracellular signal-regulated kinase-1/2 activity via 4-hydroxynonenal. JBiol Chem 2007, 282(3):1925-1937. Epub 2006/11/17, PubMed PMID: 17107949; PubMed Central PMCID: PMC2956423. 10.1074/jbc.M610602200.
9. Uygun B.E., Soto-Gutierrez A., Yagi H., et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med 2010, 16(7):814-820. Epub 2010/06/15, PubMed PMID: 20543851; PubMed Central PMCID: PMC2930603. 10.1038/nm. 2170.
10. Bao J., Shi Y., Sun H., et al. Construction of a portal implantable functional tissue-engineered liver using perfusion-decellularized matrix and hepatocytes in rats. Cell Transplant 2011, 20(5):753-766. Epub 2010/11/09, PubMed PMID: 21054928. 10.3727/096368910X536572.
11. Shupe T., Williams M., Brown A., Willenberg B., Petersen B.E. Method for the decellularization of intact rat liver. Organogenesis 2010, 6(2):134-136. Epub 2010/10/05. PubMed PMID: 20885860; PubMed Central PMCID: PMC2901817.
12. Mirmalek-Sani S.H., Sullivan D.C., Zimmerman C., Shupe T.D., Petersen B.E. Immunogenicity of decellularized porcine liver for bioengineered hepatic tissue. Am J Pathol 2013, 183(2):558-565. Epub 2013/06/12, PubMed PMID: 23747949; PubMed Central PMCID: PMC3730770. 10.1016/j.ajpath.2013.05.002.
13. Lang R., Stern M.M., Smith L., et al. Three-dimensional culture of hepatocytes on porcine liver tissue-derived extracellular matrix. Biomaterials 2011, 32(29):7042-7052. Epub 2011/07/05, PubMed PMID: 21723601. 10.1016/j.biomaterials.2011.06.005.
14. Song J.J., Kim S.S., Liu Z., et al. Enhanced invivo function of bioartificial lungs in rats. Ann Thorac Surg 2011, 92(3):998-1005. discussion - 6. Epub 2011/08/30, PubMed PMID: 21871290. 10.1016/j.athoracsur.2011.05.018.
15. Ott H.C., Clippinger B., Conrad C., et al. Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med 2010, 16(8):927-933. Epub 2010/07/16, PubMed PMID: 20628374. 10.1038/nm. 2193.
16. Petersen T.H., Calle E.A., Zhao L., et al. Tissue-engineered lungs for invivo implantation. Science 2010, 329(5991):538-541. Epub 2010/06/26, PubMed PMID: 20576850; PubMed Central PMCID: PMC3640463. 10.1126/science.1189345.
17. Cortiella J., Niles J., Cantu A., et al. Influence of acellular natural lung matrix on murine embryonic stem cell differentiation and tissue formation. Tissue Eng Part A 2010, 16(8):2565-2580. Epub 2010/04/23, PubMed PMID: 20408765. 10.1089/ten.tea.2009.0730.
18. Goh S.K., Bertera S., Olsen P., et al. Perfusion-decellularized pancreas as a natural 3D scaffold for pancreatic tissue and whole organ engineering. Biomaterials 2013, 34(28):6760-6772. Epub 2013/06/22, PubMed PMID: 23787110; PubMed Central PMCID: PMC3748589. 10.1016/j.biomaterials.2013.05.066.
19. Sullivan D.C., Mirmalek-Sani S.H., Deegan D.B., et al. Decellularization methods of porcine kidneys for whole organ engineering using a high-throughput system. Biomaterials 2012, 33(31):7756-7764. PubMed PMID: 22841923. 10.1016/j.biomaterials.2012.07.023.
20. Song J.J., Guyette J.P., Gilpin S.E., et al. Regeneration and experimental orthotopic transplantation of a bioengineered kidney. Nat Med 2013, 19(5):646-651. Epub 2013/04/16, PubMed PMID: 23584091; PubMed Central PMCID: PMC3650107. 10.1038/nm. 3154.
21. Pathare D.B., Jadhav A.S., Shingare M.S. Validated chiral liquid chromatographic method for the enantiomeric separation of pramipexole dihydrochloride monohydrate. JPharm Biomed Anal 2006, 41(4):1152-1156. Epub 2006/04/04, PubMed PMID: 16580170. 10.1016/j.jpba.2006.02.024.
22. Jadhav J.P., Govindwar S.P. Biotransformation of malachite green by Saccharomyces cerevisiae MTCC 463. Yeast 2006, 23(4):315-323. Epub 2006/03/18, PubMed PMID: 16544273. 10.1002/yea. 1356.
23. Solaroglu I., Cahill J., Jadhav V., Zhang J.H. Anovel neuroprotectant granulocyte-colony stimulating factor. Stroke 2006, 37(4):1123-1128. Epub 2006/03/04, PubMed PMID: 16514095. 10.1161/01.STR.0000208205.26253.96.
24. Suryawanshi N.P., Bhutey A.K., Nagdeote A.N., Jadhav A.A., Manoorkar G.S. Study of lipid peroxide and lipid profile in diabetes mellitus. Indian J Clin Biochem 2006, 21(1):126-130. Epub 2006/03/01, PubMed PMID: 23105583; PubMed Central PMCID: PMC3453770. 10.1007/BF02913080.
25. Turner N.J., Badylak S.F. Biologic scaffolds for musculotendinous tissue repair. Eur Cells Mater 2013, 25:130-143. PubMed PMID: 23329468.
26. Mantovani F., Trinchieri A., Castelnuovo C., Romano A.L., Pisani E. Reconstructive urethroplasty using porcine acellular matrix. Eur Urol 2003, 44(5):600-602. PubMed PMID: 14572761.
27. Crisan M., Yap S., Casteilla L., et al. Aperivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008, 3(3):301-313. PubMed PMID: 18786417. 10.1016/j.stem.2008.07.003.
28. Londono R., Jobe B.A., Hoppo T., Badylak S.F. Esophagus and regenerative medicine. World J Gastroenterol 2012, 18(47):6894-6899. PubMed PMID: 23322986; PubMed Central PMCID: PMC3531672. 10.3748/wjg.v18.i47.6894.
29. Crapo P.M., Gilbert T.W., Badylak S.F. An overview of tissue and whole organ decellularization processes. Biomaterials 2011, 32(12):3233-3243. Epub 2011/02/08, PubMed PMID: 21296410; PubMed Central PMCID: PMC3084613. 10.1016/j.biomaterials.2011.01.057.
30. Gilbert T.W., Sellaro T.L., Badylak S.F. Decellularization of tissues and organs. Biomaterials 2006, 27(19):3675-3683. Epub 2006/03/08, PubMed PMID: 16519932. 10.1016/j.biomaterials.2006.02.014.
31. Valentin J.E., Badylak J.S., McCabe G.P., Badylak S.F. Extracellular matrix bioscaffolds for orthopaedic applications. A comparative histologic study. JBone Joint Surg Am 2006, 88(12):2673-2686. PubMed PMID: 17142418. 10.2106/JBJS.E.01008.
32. Beattie A.J., Gilbert T.W., Guyot J.P., Yates A.J., Badylak S.F. Chemoattraction of progenitor cells by remodeling extracellular matrix scaffolds. Tissue Eng Part A 2009, 15(5):1119-1125. Epub 2008/10/08, PubMed PMID: 18837648; PubMed Central PMCID: PMC2789572. 10.1089/ten.tea.2008.0162.
33. Smart N.J., Marshall M., Daniels I.R. Biological meshes: a review of their use in abdominal wall hernia repairs. Surgeon 2012, 10(3):159-171. Epub 2012/03/23, PubMed PMID: 22436406. 10.1016/j.surge.2012.02.006.
34. Valentin J.E., Stewart-Akers A.M., Gilbert T.W., Badylak S.F. Macrophage participation in the degradation and remodeling of extracellular matrix scaffolds. Tissue Eng Part A 2009, 15(7):1687-1694. Epub 2009/01/08, PubMed PMID: 19125644; PubMed Central PMCID: PMC2792102. 10.1089/ten.tea.2008.0419.
35. Brennan E.P., Tang X.H., Stewart-Akers A.M., Gudas L.J., Badylak S.F. Chemoattractant activity of degradation products of fetal and adult skin extracellular matrix for keratinocyte progenitor cells. JTissue Eng Regen Med 2008, 2(8):491-498. Epub 2008/10/29, PubMed PMID: 18956412; PubMed Central PMCID: PMC2706581. 10.1002/term.123.
36. Agrawal V., Johnson S.A., Reing J., et al. Epimorphic regeneration approach to tissue replacement in adult mammals. Proc Natl Acad Sci U S A 2010, 107(8):3351-3355. Epub 2009/12/08, PubMed PMID: 19966310; PubMed Central PMCID: PMC2840465. 10.1073/pnas.0905851106.
37. Reing J.E., Zhang L., Myers-Irvin J., et al. Degradation products of extracellular matrix affect cell migration and proliferation. Tissue Eng Part A 2009, 15(3):605-614. Epub 2008/07/26, PubMed PMID: 18652541. 10.1089/ten.tea.2007.0425.
38. Keane T.J., Londono R., Turner N.J., Badylak S.F. Consequences of ineffective decellularization of biologic scaffolds on the host response. Biomaterials 2012, 33(6):1771-1781. Epub 2011/12/06, PubMed PMID: 22137126. 10.1016/j.biomaterials.2011.10.054.
39. Mase V.J., Hsu J.R., Wolf S.E., et al. Clinical application of an acellular biologic scaffold for surgical repair of a large, traumatic quadriceps femoris muscle defect. Orthopedics 2010, 33(7):511. Epub 2010/07/09, PubMed PMID: 20608620. 10.3928/01477447-20100526-24.
40. Nieponice A., McGrath K., Qureshi I., et al. An extracellular matrix scaffold for esophageal stricture prevention after circumferential EMR. Gastrointest Endosc 2009, 69(2):289-296. Epub 2008/07/29, PubMed PMID: 18657808. 10.1016/j.gie.2008.04.022.
41. Badylak S.F., Vorp D.A., Spievack A.R., et al. Esophageal reconstruction with ECM and muscle tissue in a dog model. JSurg Res 2005, 128(1):87-97. Epub 2005/06/01, PubMed PMID: 15922361. 10.1016/j.jss.2005.03.002.
42. Badylak S.F., Hoppo T., Nieponice A., et al. Esophageal preservation in five male patients after endoscopic inner-layer circumferential resection in the setting of superficial cancer: a regenerative medicine approach with a biologic scaffold. Tissue Eng Part A 2011, 17(11-12):1643-1650. Epub 2011/02/11, PubMed PMID: 21306292; PubMed Central PMCID: PMC3098955. 10.1089/ten.TEA.2010.0739.
43. Badylak S., Meurling S., Chen M., Spievack A., Simmons-Byrd A. Resorbable bioscaffold for esophageal repair in a dog model. JPediatr Surg 2000, 35(7):1097-1103. Epub 2000/08/05, PubMed PMID: 10917304. 10.1053/jpsu.2000.7834.
44. Boruch A.V., Nieponice A., Qureshi I.R., Gilbert T.W., Badylak S.F. Constructive remodeling of biologic scaffolds is dependent on early exposure to physiologic bladder filling in a canine partial cystectomy model. JSurg Res 2010, 161(2):217-225. Epub 2009/07/07, PubMed PMID: 19577253. 10.1016/j.jss.2009.02.014.
45. Kropp B.P., Badylak S., Thor K.B. Regenerative bladder augmentation: a review of the initial preclinical studies with porcine small intestinal submucosa. Adv Exp Med Biol 1995, 385:229-235. Epub 1995/01/01. PubMed PMID: 8571835.
46. Li F., Li W., Johnson S., et al. Low-molecular-weight peptides derived from extracellular matrix as chemoattractants for primary endothelial cells. Endothelium 2004, 11(3-4):199-206. PubMed PMID: 15370297.
47. Agrawal V., Tottey S., Johnson S.A., et al. Recruitment of progenitor cells by an extracellular matrix cryptic peptide in a mouse model of digit amputation. Tissue Eng Part A 2011, 17(19-20):2435-2443. Epub 2011/05/14, PubMed PMID: 21563860; PubMed Central PMCID: PMC3179613. 10.1089/ten.TEA.2011.0036.
48. Crapo P.M., Medberry C.J., Reing J.E., et al. Biologic scaffolds composed of central nervous system extracellular matrix. Biomaterials 2012, 33(13):3539-3547. Epub 2012/02/22. doi: S0142-9612(12)00090-7 [pii]10.1016/j.biomaterials.2012.01.044. PubMed PMID: 22341938.
49. DeQuach J.A., Yuan S.H., Goldstein L.S., Christman K.L. Decellularized porcine brain matrix for cell culture and tissue engineering scaffolds. Tissue Eng Part A 2011, 17(21-22):2583-2592. Epub 2011/09/03, PubMed PMID: 21883047; PubMed Central PMCID: PMC3204197. 10.1089/ten.TEA.2010.0724.
50. Tottey S., Corselli M., Jeffries E.M., et al. Extracellular matrix degradation products and low-oxygen conditions enhance the regenerative potential of perivascular stem cells. Tissue Eng Part A 2011, 17(1-2):37-44. Epub 2010/07/27, PubMed PMID: 20653348; PubMed Central PMCID: PMC3011908. 10.1089/ten.TEA.2010.0188.
51. Voytik-Harbin S.L., Brightman A.O., Kraine M.R., Waisner B., Badylak S.F. Identification of extractable growth factors from small intestinal submucosa. JCell Biochem 1997, 67(4):478-491. Epub 1998/01/24, 4<478::AID-JCB6>3.0.CO;2-P [pii]. PubMed PMID: 9383707. 10.1002/(SICI)1097-4644(19971215)67.
52. Agrawal V., Kelly J., Tottey S., et al. An isolated cryptic peptide influences osteogenesis and bone remodeling in an adult mammalian model of digit amputation. Tissue Eng Part A 2011, 17(23-24):3033-3044. Epub 2011/07/12, PubMed PMID: 21740273; PubMed Central PMCID: PMC3226059. 10.1089/ten.TEA.2011.0257.
53. Badylak S.F., Valentin J.E., Ravindra A.K., McCabe G.P., Stewart-Akers A.M. Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Eng Part A 2008, 14(11):1835-1842. Epub 2008/10/28, PubMed PMID: 18950271. 10.1089/ten.tea.2007.0264.
54. Badylak S.F., Gilbert T.W. Immune response to biologic scaffold materials. Semin Immunol 2008, 20(2):109-116. Epub 2007/12/18, PubMed PMID: 18083531; PubMed Central PMCID: PMC2605275. 10.1016/j.smim.2007.11.003.
55. Brown B.N., Valentin J.E., Stewart-Akers A.M., McCabe G.P., Badylak S.F. Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component. Biomaterials 2009, 30(8):1482-1491. Epub 2009/01/06, PubMed PMID: 19121538; PubMed Central PMCID: PMC2805023. 10.1016/j.biomaterials.2008.11.040.
56. Brown B.N., Londono R., Tottey S., et al. Macrophage phenotype as a predictor of constructive remodeling following the implantation of biologically derived surgical mesh materials. Acta Biomater 2012, 8(3):978-987. Epub 2011/12/15, PubMed PMID: 22166681. 10.1016/j.actbio.2011.11.031.
57. Brown B.N., Ratner B.D., Goodman S.B., Amar S., Badylak S.F. Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine. Biomaterials 2012, 33(15):3792-3802. Epub 2012/03/06, PubMed PMID: 22386919; PubMed Central PMCID: PMC3727238. 10.1016/j.biomaterials.2012.02.034.
58. Gardner A.B., Lee S.K., Woods E.C., Acharya A.P. Biomaterials-based modulation of the immune system. Biomed Res Int 2013, 2013:732182. Epub 2013/10/31, PubMed PMID: 24171170; PubMed Central PMCID: PMC3793288. 10.1155/2013/732182.
59. Gilbert T.W., Stewart-Akers A.M., Simmons-Byrd A., Badylak S.F. Degradation and remodeling of small intestinal submucosa in canine Achilles tendon repair. JBone Joint Surg Am 2007, 89(3):621-630. Epub 2007/03/03, PubMed PMID: 17332112. 10.2106/JBJS.E.00742.
60. Badylak S.F. An assay to quantify chemotactic properties of degradation products from extracellular matrix. Methods Mol Biol 2013, Epub 2013/10/25, PubMed PMID: 24155230. 10.1007/7651_2013_37.
61. Brennan E.P., Reing J., Chew D., et al. Antibacterial activity within degradation products of biological scaffolds composed of extracellular matrix. Tissue Eng 2006, 12(10):2949-2955. Epub 2007/05/24, PubMed PMID: 17518662; PubMed Central PMCID: PMC3056877. 10.1089/ten.2006.12.2949.
62. Lin P., Chan W.C., Badylak S.F., Bhatia S.N. Assessing porcine liver-derived biomatrix for hepatic tissue engineering. Tissue Eng 2004, 10(7-8):1046-1053. Epub 2004/09/15, PubMed PMID: 15363162. 10.1089/ten.2004.10.1046.
63. Sellaro T.L., Ranade A., Faulk D.M., et al. Maintenance of human hepatocyte function invitro by liver-derived extracellular matrix gels. Tissue Eng Part A 2010, 16(3):1075-1082. Epub 2009/10/23, PubMed PMID: 19845461; PubMed Central PMCID: PMC2863084. 10.1089/ten.TEA.2008.0587.
64. Sellaro T.L., Ravindra A.K., Stolz D.B., Badylak S.F. Maintenance of hepatic sinusoidal endothelial cell phenotype invitro using organ-specific extracellular matrix scaffolds. Tissue Eng 2007, 13(9):2301-2310. Epub 2007/06/15, PubMed PMID: 17561801. 10.1089/ten.2006.0437.
65. Weymann A., Loganathan S., Takahashi H., et al. Development and evaluation of a perfusion decellularization porcine heart model-generation of 3-dimensional myocardial neoscaffolds. Circ J 2011, 75(4):852-860. official journal of the Japanese Circulation Society, PubMed PMID: 21301134.
66. Ott H.C., Matthiesen T.S., Goh S.K., et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 2008, 14(2):213-221. PubMed PMID: 18193059. 10.1038/nm1684.
67. Wainwright J.M., Czajka C.A., Patel U.B., et al. Preparation of cardiac extracellular matrix from an intact porcine heart. Tissue Eng Part C Methods 2010, 16(3):525-532. PubMed PMID: 19702513; PubMed Central PMCID: PMC2945869. 10.1089/ten.TEC.2009.0392.
68. Keane T.J., Londono R., Carey R.M., et al. Preparation and characterization of a biologic scaffold from esophageal mucosa. Biomaterials 2013, 34(28):6729-6737. Epub 2013/06/20, PubMed PMID: 23777917; PubMed Central PMCID: PMC3727430. 10.1016/j.biomaterials.2013.05.052.
69. Baptista P.M., Siddiqui M.M., Lozier G., et al. The use of whole organ decellularization for the generation of a vascularized liver organoid. Hepatology 2011, 53(2):604-617. Epub 2011/01/29, PubMed PMID: 21274881. 10.1002/hep.24067.
70. Hudson T.W., Liu S.Y., Schmidt C.E. Engineering an improved acellular nerve graft via optimized chemical processing. Tissue Eng 2004, 10(9-10):1346-1358. Epub 2004/12/14, PubMed PMID: 15588395. 10.1089/ten.2004.10.1346.
71. Courtman D.W., Pereira C.A., Kashef V., et al. Development of a pericardial acellular matrix biomaterial: biochemical and mechanical effects of cell extraction. JBiomed Mater Res 1994, 28(6):655-666. Epub 1994/06/01, PubMed PMID: 8071376. 10.1002/jbm.820280602.
72. Brown B., Lindberg K., Reing J., Stolz D.B., Badylak S.F. The basement membrane component of biologic scaffolds derived from extracellular matrix. Tissue Eng 2006, 12(3):519-526. Epub 2006/04/04, PubMed PMID: 16579685. 10.1089/ten.2006.12.519.
73. Kasimir M.T., Rieder E., Seebacher G., et al. Comparison of different decellularization procedures of porcine heart valves. Int J Artif Organs 2003, 26(5):421-427. Epub 2003/06/28. PubMed PMID: 12828309.
74. Faulk D.M., Carruthers C.A., Warner H.J., et al. The effect of detergents on the basement membrane complex of a biologic scaffold material. Acta Biomater 2014, 10(1):183-193. Epub 2013/09/24, PubMed PMID: 24055455. 10.1016/j.actbio.2013.09.006.
75. Kmiec Z. Cooperation of liver cells in health and disease. Adv Anat Embryol Cell Biol 2001, 161(III-XIII):1-151. PubMed PMID: 11729749.
76. Bhatia S.N., Balis U.J., Yarmush M.L., Toner M. Microfabrication of hepatocyte/fibroblast co-cultures: role of homotypic cell interactions. Biotechnol Prog 1998, 14(3):378-387. Epub 1998/06/17, PubMed PMID: 9622518. 10.1021/bp980036j.
77. Bhatia S.N., Balis U.J., Yarmush M.L., Toner M. Effect of cell-cell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and nonparenchymal cells. FASEB J 1999, 13(14):1883-1900. Epub 1999/11/02. PubMed PMID: 10544172.